Stesolid

Diazepam

Method of action: Antianxiety, Anticonvulsant, Anxiolytic, Hypnotic, Muscle Relaxant, Psycholeptics, Sedative, Tranquilizing

Treatment option: Alcoholism, Alcohol Dependence And Withdrawal, Arteriosclerosis/Atherosclerosis, Insomnia, Pain, Hypertension, Headache, Muscle Cramp, Neurosis, Anxiety&Panic Attacks

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Stesolid

Property	Description
Active Ingredient	Diazepam (C16H13ClN2O)
Pharmacological Class	Benzodiazepine Derivative, CNS Depressant
Form	Tablet, Solution (Oral, Rectal, Injectable), Suppository
Common Use	Relief of severe tension, anxiety, and muscle spasm
Origin	Synthetic Compound, Single-ingredient product

What Type of Medicine is Stesolid (Diazepam)?

Stesolid is a prescription-only medicine whose active ingredient is Diazepam, belonging to the powerful benzodiazepine derivative pharmacological class. This synthetic compound is classified as a Central Nervous System (CNS) depressant and a psychotropic agent, signifying its primary function is to reduce and stabilize excessive neurological activity within the brain and spinal cord. Diazepam is a well-established agent in its class, a foundational component in the management of various states of excitability.

The drug's structure is that of a single-ingredient product whose therapeutic properties derive solely from the action of Diazepam. This CNS activity is clinically recognized for its effectiveness in rapidly calming overactive neural pathways.

Composition, Available Forms, and General Purpose

The compound is prepared in several distinct dosage forms to accommodate various administration needs, including the standard tablet and oral solution, as well as specialized preparations such as the suppository, rectal solution, and the solution for injection used for Parenteral administration.

Its general therapeutic purpose is to alleviate states of severe neurological and muscular over-excitability. It achieves this by functioning as a GABA receptor positive allosteric modulator, essentially amplifying the effects of GABA (gamma-aminobutyric acid), the brain's natural inhibitory neurotransmitter. By enhancing this inhibitory neurotransmission, the medicine helps to reduce severe tension, pronounced anxiety, and unwanted skeletal muscle spasm, leading to generalized stabilization of the affected systems.

What side effects are possible with Stesolid?

Official Classification of Possible Side Effects

The safety profile of Stesolid (Diazepam) is documented by regulatory authorities, which classify adverse reactions based on their frequency and the body system affected. The most frequently observed effects are related to the central nervous system (CNS).

Commonly Documented Adverse Reactions (CNS Focus)

Adverse reactions classified as common in official labeling primarily affect the nervous system and include somnolence (drowsiness), fatigue, and ataxia (a lack of muscle coordination). Less common effects documented are dysarthria (slurred speech), dizziness, and confusion. These effects are often noted as being more pronounced at the start of treatment or following a dose increase.

Serious Adverse Reactions and Systemic Concerns

The official safety information highlights the risk of rare, but serious, adverse reactions. These include respiratory depression, which can be life-threatening, particularly with high doses or concurrent use of other CNS depressants. Other serious reactions are jaundice (indicating liver dysfunction) and paradoxical reactions, such as increased aggression, agitation, or rage, which require clinical attention.

Safety Considerations by Population and Duration

Regulatory documents explicitly state that older adults have an increased sensitivity to the CNS effects of Diazepam and are at higher risk for side effects like sedation and falls. Furthermore, the drug is contraindicated (should not be used) in patients with conditions such as severe respiratory insufficiency, myasthenia gravis, and severe hepatic insufficiency.

Regarding duration, the risk of developing physical and psychological dependence and abuse increases with long-term use and higher doses. Abrupt cessation following chronic use may lead to withdrawal symptoms or a rebound phenomenon where original symptoms temporarily return in an enhanced form.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory information mandates immediate emergency action if an overdose of Stesolid (Diazepam) is suspected. The core manifestations of overdose are extensions of the drug's Central Nervous System (CNS) depressant activity, which may range from mild to life-threatening.

Documented Overdose Manifestations

Clinical signs of overdose include drowsiness, mental confusion, impaired reflexes, dizziness, and slurred speech. Severe toxicity is formally documented to lead to profound sedation and coma. The most serious outcomes listed are respiratory depression, apnea (breathing stops), and cardiac arrest, particularly in elderly or very ill patients. The risk of these severe consequences is significantly increased by co-ingestion with opioids or other CNS depressants, a combination noted to increase the risk of death.

Mandated Emergency Action

If an overdose is suspected, official labeling requires individuals to seek immediate medical attention and get emergency help right away. Management procedures involve symptomatic and supportive treatment and hospital monitoring until symptoms resolve. The specific antagonist Flumazenil is officially available to reverse the sedative effects, though careful observation for re-sedation is required if it is administered.

Therapeutic Uses of Stesolid

Stesolid (Diazepam) is commonly used to provide symptomatic relief across several key areas of heightened neurological activity. Its therapeutic domains are relevant in contexts involving heightened systemic burden.

The medication is generally applied in addressing conditions presenting with disruptive symptom manifestations, notably severe anxiety states, skeletal muscle spasm, status epilepticus, and symptomatic relief of acute alcohol withdrawal. This means it is used when symptoms escalate temporarily and short-term symptomatic assistance is needed. One of its benefits is that it supports patients during difficult episodes by easing distress and may assist with maintaining functional stability when symptoms are more noticeable.

“Stesolid is often applied in clinical settings that involve acute or unstable symptom patterns, offering supportive relief when symptoms interfere with routine activities.”

Quick Fact: Supports Management of Heightened Symptoms

Stesolid is considered relevant across domains where additional symptomatic support is needed, and is relevant for addressing symptom clusters related to increased neurological or muscular activity and heightened physiological activity. This is relevant for managing symptoms of increased neurological or muscular activity, agitation, severe tension, and convulsive activity.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Stesolid — Official Regulatory Information

The following information is derived from official governmental regulatory documents and outlines the formal eligibility constraints for using Stesolid (diazepam rectal solution).

Eligibility Scope

Category	Official Regulatory Statement
Populations for whom use is contraindicated:	Patients with Myasthenia Gravis, Severe Respiratory Insufficiency, Severe Hepatic Insufficiency, Sleep Apnoea Syndrome, Acute Narrow-Angle Glaucoma, or known hypersensitivity to diazepam or its ingredients.
Age-related eligibility rules:	Safety and effectiveness are not established for infants under 6 months. The elderly and debilitated patients must receive a significantly reduced dose due to increased sensitivity. The U.S. label specifies use for patients aged 2 years and older for seizure clusters.
Condition-specific eligibility rules:	Use requires caution and potential dose reduction in patients with chronic respiratory insufficiency, chronic hepatic disorders, renal dysfunction, or a history of alcohol/drug abuse.
Pregnancy and lactation eligibility status:	Use is generally contraindicated or should be avoided during the first and third trimesters of pregnancy. Use is avoided while breastfeeding as the drug is excreted into breast milk.

Connection to the Overall Eligibility Profile

Regulatory documents establish strict eligibility by defining absolute contraindications (e.g., severe organ failure or specific neuromuscular conditions) that mandate non-use. Eligibility is further limited by age and organ function, requiring mandatory dose reduction for the elderly and those with chronic hepatic or respiratory impairment. These constraints ensure the medicine is only used by populations where the official risk profile is managed.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documentation for Stesolid (diazepam) outlines specific constraints regarding co-administration with other substances, categorized by their potential to affect the drug’s concentration or activity in the body.

Interacting Product Categories

Interaction Mechanism	Interacting Substance Category	Practical Implication
Pharmacodynamic (PD)	Opioids & CNS Depressants (e.g., other sedatives, alcohol)	May result in increased central nervous system depression, potentially leading to profound sedation and respiratory depression.
Pharmacokinetic (PK)	CYP Enzyme Inhibitors (e.g., cimetidine, ketoconazole)	May significantly decrease the drug's elimination rate, leading to increased plasma concentrations and exposure.
Pharmacokinetic (PK)	CYP Enzyme Inducers (e.g., rifampin, phenytoin)	May significantly increase the drug's elimination rate, leading to decreased plasma concentrations and exposure.

Specific Interaction Constraints

Opioid Co-administration: The use of Stesolid with opioids is a significant regulatory concern and is typically reserved for cases where alternative treatment options are inadequate, requiring close monitoring for signs of sedation and breathing difficulties.
Food and Beverages: Taking the drug with a moderate fat meal delays and decreases its absorption, resulting in lower peak concentrations. Ingestion of alcohol is strongly advised against due to the risk of heightened CNS depression. Grapefruit juice may also increase the drug's exposure.

Mechanism of Action

Stesolid, a benzodiazepine, functions by allosterically modulating the activity of the gamma-aminobutyric acid type A ( GABA A) receptor. This interaction potentiates the inhibitory effects of the endogenous neurotransmitter GABA.

Binding to a specific site on the GABA A receptor, distinct from the GABA site, increases the frequency of chloride ion channel opening. The resulting influx of chloride ions leads to hyperpolarization of the neuronal membrane.

This process decreases neuronal excitability across the central nervous system, particularly in the limbic system, thalamus, hypothalamus, and spinal cord. The resulting increased neuronal inhibitory effect modulates overactive nerve signaling and decreases motor neuron excitability across these neural circuits.

Dosage and Administration Information

The use of Stesolid (diazepam) is strictly defined by the purpose and the chosen route of administration, which includes oral (tablets or solution), intravenous (IV), intramuscular (IM), and rectal formulations. Dosing is highly regimen-dependent.

For routine oral administration, the dose typically ranges from 2 mg to 10 mg, taken two to four times a day in divided doses. Oral tablets may be taken with or without food. Continuous therapy is generally restricted to a short duration only, and prolonged use must be followed by a gradual dose reduction (tapering) upon cessation.

The parenteral (IV/IM) and rectal forms are reserved for acute interventions. Intravenous administration requires specific procedural constraints: the solution must be injected slowly, taking at least one minute for each 5 mg administered, and the solution must not be mixed or diluted in a syringe with other drugs. Following acute parenteral administration, patients must remain under observation.

Rectal administration for acute seizure management is intermittent and subject to strict frequency limits. Use should not exceed one episode every five days or a total of five episodes per month. Dosing must also be adjusted for specific patient populations; the elderly and debilitated patients must initiate therapy with a reduced dose, typically 2 mg to 2.5 mg one or two times daily.

Recent Clinical Evidence

Research evidence / Overview of Studies for Stesolid (Diazepam)

This section provides a summary of the available clinical research for Stesolid (Diazepam), outlining the types of studies that have been conducted, the specific outcomes measured, and the known limitations or gaps in the evidence, according to official regulatory and scientific sources. Findings describe group patterns and do not determine whether an individual will respond similarly.

Evidence for Use in Severe Anxiety States

The research base consists primarily of short-term randomized controlled trials (RCTs) and meta-analyses that have examined changes in anxiety scale scores and patient responses. These trials typically focused on short-term symptom patterns, generally over a period of just a few weeks. What remains uncertain is the durability of these patterns; clinical studies supporting the investigation of clinical utility beyond four months of continuous use have not been fully established. Research, therefore, provides limited insight into long-term functional outcomes.

Evidence for Use in Acute Situations

Acute Alcohol Withdrawal: Foundational randomized clinical trials and comprehensive reviews have investigated outcomes related to withdrawal symptoms and the prevention of severe complications like seizures. Findings describe the drug class's role in the acute phase, with patterns observed where the medication was associated with differences in outcomes related to systemic imbalance. Research is ongoing to refine optimal administration for diverse patient groups.

Acute Seizure Management: Evidence features double-blind RCTs exploring acute, high-symptom activity scenarios in adult and pediatric populations. Studies focused on outcomes such as the frequency of seizure cessation and the time required to stop the seizure. The research indicates that tolerance to the anticonvulsant properties generally develops with continuous use over months, and it is generally not studied for long-term primary epilepsy management.

Evidence Gaps and Special Populations

Long-term patterns of change are not fully established for several conditions, particularly concerning the durability of response and the potential for the development of tolerance to muscle-relaxant properties. For older adults, the research describes patterns suggesting a need to evaluate the drug's clearance due to differences in metabolism. Overall, data for certain groups remain insufficient, and findings often describe group patterns rather than personal outcomes.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Stesolid (FAQ)

Q: Can Stesolid be taken with or without food?

Official product information indicates that Stesolid may be taken with or without food. However, taking the drug with a meal, particularly one containing a moderate amount of fat, has been shown to slow down and reduce the amount of the drug absorbed into the body. This is a pharmacokinetic effect that may influence the time it takes for the effects to begin.

Q: What happens if I miss a dose of the oral tablet?

Patient information guides suggest taking the dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should generally be skipped to resume the regular schedule. It is important to avoid taking two doses at the same time to make up for a missed dose.

Q: What should I do if I overdose on Stesolid?

Official labeling for Stesolid highlights that an overdose can lead to serious central nervous system effects, including extreme drowsiness, loss of coordination, slow breathing, and in severe cases, coma. Official labeling directs seeking emergency medical attention or contacting a poison control center immediately if there is concern about an overdose.

Q: How should I dispose of unused or expired Stesolid?

Due to its status as a controlled substance, disposal should follow local and federal regulations, often utilizing drug take-back programs to prevent diversion. Specific disposal instructions for unused medicine, which may vary by dosage form (such as the rectal gel), are typically provided by the manufacturer and the FDA.

Q: How long does it take for Stesolid oral tablets to start working?

Official pharmacokinetic studies indicate that Stesolid (diazepam) is absorbed rapidly after oral administration. The concentration of the drug reaches its highest level in the bloodstream—often associated with the peak effect—within about one to one-and-a-half hours.

Q: What should pregnant women do if they are taking Stesolid and want to stop?

Official documents caution against using Stesolid during pregnancy, particularly during the first and third trimesters. If a woman is taking the drug and becomes pregnant or wishes to stop, consultation with a healthcare provider is necessary. Stopping this medicine suddenly may lead to withdrawal symptoms or the return of the original condition.

Q: Is Stesolid a narcotic?

No, Stesolid's active ingredient, diazepam, is not classified as a narcotic. It belongs to the benzodiazepine class of medicines, which are central nervous system depressants. Regulatory authorities classify it as a Schedule IV controlled substance due to its potential for dependence and abuse.

How should Stesolid be stored and disposed of?

Storage and Disposal of Stesolid (Diazepam Rectal Gel)

Official regulatory documentation specifies precise storage and disposal requirements for Stesolid, which contains the controlled substance Diazepam.

Storage Requirements

Stesolid must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The product must be stored in its original, tightly closed container and should be protected from light. It is explicitly stated that the medicine must not be frozen or refrigerated. To prevent accidental exposure, the product must be kept out of the sight and reach of children and pets.

Disposal Instructions

Disposal must adhere to the rules for controlled substances. The preferred method is returning unused or expired product through an official drug take-back program. If a program is unavailable, certain rectal gel formulations are recommended by the FDA to be immediately discarded by flushing down a toilet or sink to prevent diversion or misuse. All disposal must comply with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.